Equine Veterinary Therapeutics Market, Global Outlook and Forecast 2023-2029
Report ID
39046
Publisher
Market Monitor Global
Published Date
03-Nov
Delivery Format
PDF
No of Report Page
61
Editor's Rating
US $3,250.00
US $4,225.00
US $4,875.00
  • Report Details 
    This research report provides a comprehensive analysis of the Equine Veterinary Therapeutics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Equine Veterinary Therapeutics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Equine Veterinary Therapeutics, challenges faced by the industry, and potential opportunities for market players.
The global Equine Veterinary Therapeutics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Equine Veterinary Therapeutics market presents opportunities for various stakeholders, including Veterinary Hospital, Veterinary Clinics. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Equine Veterinary Therapeutics market. Additionally, the growing consumer demand present avenues for market expansion.
The global Equine Veterinary Therapeutics market was valued at US$ 1186.5 million in 2022 and is projected to reach US$ 1968 million by 2029, at a CAGR of 7.2% during the forecast period.
A significant driver in the Equine Veterinary Therapeutics market is the growing demand for high-quality healthcare and treatment options for horses. As the importance of equines in various sectors, including sports, agriculture, and leisure, continues to rise, there is an increased emphasis on maintaining their health and performance. This drives the demand for innovative veterinary therapeutics, such as advanced medications, surgical techniques, and rehabilitation methods, to address a wide range of equine health issues. One of the key challenges in this market is the cost associated with advanced equine veterinary care. High-end treatments, specialized surgeries, and cutting-edge therapies can be expensive, which may limit access for some horse owners or require substantial investments. Additionally, ensuring the safety and effectiveness of equine therapeutics can be challenging due to the size and unique physiology of horses, requiring specialized expertise and equipment. Regulatory compliance and ensuring the welfare of the animals also pose ongoing challenges in this industry.
Key Features:
The research report on the Equine Veterinary Therapeutics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Equine Veterinary Therapeutics market.
Market Overview: The report provides a comprehensive overview of the Equine Veterinary Therapeutics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Drugs, Vaccine), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Equine Veterinary Therapeutics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Equine Veterinary Therapeutics market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Equine Veterinary Therapeutics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. 
Market Segmentation and Forecast: The report segment the Equine Veterinary Therapeutics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Equine Veterinary Therapeutics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Equine Veterinary Therapeutics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Equine Veterinary Therapeutics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Equine Veterinary Therapeutics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Equine Veterinary Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
    Drugs
    Vaccine
    Other
Market segment by Application
    Veterinary Hospital
    Veterinary Clinics
    Other
Global Equine Veterinary Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Major players covered
    Boehringer Ingelheim
    Merck Animal Health
    Zoetis
    Elanco Animal Health
    Dechra Veterinary Products
    CEVA
    Virbac
    Norbrook Equine
    Kyoritsu Seiyaku
    Vetoquinol
    Protexin Healthcare
    Audevard
Outline of Major Chapters:
Chapter 1: Introduces the definition of Equine Veterinary Therapeutics, market overview.
Chapter 2: Global Equine Veterinary Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Equine Veterinary Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Equine Veterinary Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
  • Table Of Content 
    1 Introduction to Research & Analysis Reports
    1.1 Equine Veterinary Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Equine Veterinary Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Equine Veterinary Therapeutics Overall Market Size
    2.1 Global Equine Veterinary Therapeutics Market Size: 2022 VS 2029
    2.2 Global Equine Veterinary Therapeutics Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Equine Veterinary Therapeutics Players in Global Market
    3.2 Top Global Equine Veterinary Therapeutics Companies Ranked by Revenue
    3.3 Global Equine Veterinary Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Equine Veterinary Therapeutics Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Equine Veterinary Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Equine Veterinary Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Equine Veterinary Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Equine Veterinary Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Equine Veterinary Therapeutics Market Size Markets, 2022 & 2029
        4.1.2 Drugs
        4.1.3 Vaccine
        4.1.4 Other
    4.2 By Type - Global Equine Veterinary Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Equine Veterinary Therapeutics Revenue, 2018-2023
        4.2.2 By Type - Global Equine Veterinary Therapeutics Revenue, 2024-2029
        4.2.3 By Type - Global Equine Veterinary Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Equine Veterinary Therapeutics Market Size, 2022 & 2029
        5.1.2 Veterinary Hospital
        5.1.3 Veterinary Clinics
        5.1.4 Other
    5.2 By Application - Global Equine Veterinary Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Equine Veterinary Therapeutics Revenue, 2018-2023
        5.2.2 By Application - Global Equine Veterinary Therapeutics Revenue, 2024-2029
        5.2.3 By Application - Global Equine Veterinary Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Equine Veterinary Therapeutics Market Size, 2022 & 2029
    6.2 By Region - Global Equine Veterinary Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Equine Veterinary Therapeutics Revenue, 2018-2023
        6.2.2 By Region - Global Equine Veterinary Therapeutics Revenue, 2024-2029
        6.2.3 By Region - Global Equine Veterinary Therapeutics Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Equine Veterinary Therapeutics Revenue, 2018-2029
        6.3.2 US Equine Veterinary Therapeutics Market Size, 2018-2029
        6.3.3 Canada Equine Veterinary Therapeutics Market Size, 2018-2029
        6.3.4 Mexico Equine Veterinary Therapeutics Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Equine Veterinary Therapeutics Revenue, 2018-2029
        6.4.2 Germany Equine Veterinary Therapeutics Market Size, 2018-2029
        6.4.3 France Equine Veterinary Therapeutics Market Size, 2018-2029
        6.4.4 U.K. Equine Veterinary Therapeutics Market Size, 2018-2029
        6.4.5 Italy Equine Veterinary Therapeutics Market Size, 2018-2029
        6.4.6 Russia Equine Veterinary Therapeutics Market Size, 2018-2029
        6.4.7 Nordic Countries Equine Veterinary Therapeutics Market Size, 2018-2029
        6.4.8 Benelux Equine Veterinary Therapeutics Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Equine Veterinary Therapeutics Revenue, 2018-2029
        6.5.2 China Equine Veterinary Therapeutics Market Size, 2018-2029
        6.5.3 Japan Equine Veterinary Therapeutics Market Size, 2018-2029
        6.5.4 South Korea Equine Veterinary Therapeutics Market Size, 2018-2029
        6.5.5 Southeast Asia Equine Veterinary Therapeutics Market Size, 2018-2029
        6.5.6 India Equine Veterinary Therapeutics Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Equine Veterinary Therapeutics Revenue, 2018-2029
        6.6.2 Brazil Equine Veterinary Therapeutics Market Size, 2018-2029
        6.6.3 Argentina Equine Veterinary Therapeutics Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Equine Veterinary Therapeutics Revenue, 2018-2029
        6.7.2 Turkey Equine Veterinary Therapeutics Market Size, 2018-2029
        6.7.3 Israel Equine Veterinary Therapeutics Market Size, 2018-2029
        6.7.4 Saudi Arabia Equine Veterinary Therapeutics Market Size, 2018-2029
        6.7.5 UAE Equine Veterinary Therapeutics Market Size, 2018-2029
7 Equine Veterinary Therapeutics Companies Profiles
    7.1 Boehringer Ingelheim
        7.1.1 Boehringer Ingelheim Company Summary
        7.1.2 Boehringer Ingelheim Business Overview
        7.1.3 Boehringer Ingelheim Equine Veterinary Therapeutics Major Product Offerings
        7.1.4 Boehringer Ingelheim Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
        7.1.5 Boehringer Ingelheim Key News & Latest Developments
    7.2 Merck Animal Health
        7.2.1 Merck Animal Health Company Summary
        7.2.2 Merck Animal Health Business Overview
        7.2.3 Merck Animal Health Equine Veterinary Therapeutics Major Product Offerings
        7.2.4 Merck Animal Health Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
        7.2.5 Merck Animal Health Key News & Latest Developments
    7.3 Zoetis
        7.3.1 Zoetis Company Summary
        7.3.2 Zoetis Business Overview
        7.3.3 Zoetis Equine Veterinary Therapeutics Major Product Offerings
        7.3.4 Zoetis Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
        7.3.5 Zoetis Key News & Latest Developments
    7.4 Elanco Animal Health
        7.4.1 Elanco Animal Health Company Summary
        7.4.2 Elanco Animal Health Business Overview
        7.4.3 Elanco Animal Health Equine Veterinary Therapeutics Major Product Offerings
        7.4.4 Elanco Animal Health Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
        7.4.5 Elanco Animal Health Key News & Latest Developments
    7.5 Dechra Veterinary Products
        7.5.1 Dechra Veterinary Products Company Summary
        7.5.2 Dechra Veterinary Products Business Overview
        7.5.3 Dechra Veterinary Products Equine Veterinary Therapeutics Major Product Offerings
        7.5.4 Dechra Veterinary Products Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
        7.5.5 Dechra Veterinary Products Key News & Latest Developments
    7.6 CEVA
        7.6.1 CEVA Company Summary
        7.6.2 CEVA Business Overview
        7.6.3 CEVA Equine Veterinary Therapeutics Major Product Offerings
        7.6.4 CEVA Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
        7.6.5 CEVA Key News & Latest Developments
    7.7 Virbac
        7.7.1 Virbac Company Summary
        7.7.2 Virbac Business Overview
        7.7.3 Virbac Equine Veterinary Therapeutics Major Product Offerings
        7.7.4 Virbac Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
        7.7.5 Virbac Key News & Latest Developments
    7.8 Norbrook Equine
        7.8.1 Norbrook Equine Company Summary
        7.8.2 Norbrook Equine Business Overview
        7.8.3 Norbrook Equine Equine Veterinary Therapeutics Major Product Offerings
        7.8.4 Norbrook Equine Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
        7.8.5 Norbrook Equine Key News & Latest Developments
    7.9 Kyoritsu Seiyaku
        7.9.1 Kyoritsu Seiyaku Company Summary
        7.9.2 Kyoritsu Seiyaku Business Overview
        7.9.3 Kyoritsu Seiyaku Equine Veterinary Therapeutics Major Product Offerings
        7.9.4 Kyoritsu Seiyaku Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
        7.9.5 Kyoritsu Seiyaku Key News & Latest Developments
    7.10 Vetoquinol
        7.10.1 Vetoquinol Company Summary
        7.10.2 Vetoquinol Business Overview
        7.10.3 Vetoquinol Equine Veterinary Therapeutics Major Product Offerings
        7.10.4 Vetoquinol Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
        7.10.5 Vetoquinol Key News & Latest Developments
    7.11 Protexin Healthcare
        7.11.1 Protexin Healthcare Company Summary
        7.11.2 Protexin Healthcare Business Overview
        7.11.3 Protexin Healthcare Equine Veterinary Therapeutics Major Product Offerings
        7.11.4 Protexin Healthcare Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
        7.11.5 Protexin Healthcare Key News & Latest Developments
    7.12 Audevard
        7.12.1 Audevard Company Summary
        7.12.2 Audevard Business Overview
        7.12.3 Audevard Equine Veterinary Therapeutics Major Product Offerings
        7.12.4 Audevard Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
        7.12.5 Audevard Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
Email: inquiry@wiredrelease.com
SHORT NAVIGATION
connect with us